Cantabio Pharmaceuticals Inc (CTBO)
1.01
0.00 (0.00%)
USD |
OTCM |
May 16, 16:00
Cantabio Pharmaceuticals Net Income (Quarterly): 0.343M for Dec. 31, 2018
Net Income (Quarterly) Chart
Historical Net Income (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2018 | 0.343M |
| September 30, 2018 | -0.5686M |
| June 30, 2018 | -0.4669M |
| March 31, 2018 | -0.8506M |
| December 31, 2017 | -0.4635M |
| September 30, 2017 | -0.3453M |
| June 30, 2017 | -0.3524M |
| March 31, 2017 | -0.3254M |
| December 31, 2016 | -0.2273M |
| September 30, 2016 | -0.2935M |
| June 30, 2016 | -0.2659M |
| March 31, 2016 | -0.4321M |
| December 31, 2015 | -0.0655M |
| September 30, 2015 | -0.1543M |
| Date | Value |
|---|---|
| June 30, 2015 | -0.0994M |
| March 31, 2015 | 0.023M |
| December 31, 2014 | 0.0181M |
| September 30, 2014 | -0.0143M |
| June 30, 2014 | -0.003M |
| March 31, 2014 | -0.0256M |
| December 31, 2013 | -0.0243M |
| September 30, 2013 | -0.0207M |
| June 30, 2013 | -0.0162M |
| March 31, 2013 | -0.02M |
| December 31, 2012 | -0.0022M |
| September 30, 2012 | -0.0025M |
| June 30, 2012 | -0.0018M |
Net Income Definition
Net Income is the total amount of profit earned by a company. This metric boils down to the overall profit that is left from the revenue that a company receives after taking out various operational line items like cost of goods sold, income tax expense, SG&A expense, etc. Eventually, all companies would want to have a consistent positive and growing net income, so that this can be used for various purposes like reinvesting into the company, paying off debt, and potentially paying out dividends to shareholders.
Net Income (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Net Income (Quarterly) Benchmarks
| Humanigen Inc | -4.182M |
| Cannabis Global Inc | -0.4746M |
| Item 9 Labs Corp | -5.911M |
| Affymax Inc | -- |
| Statera BioPharma Inc | -3.349M |
Net Income (Quarterly) Related Metrics
| Total Expenses (Quarterly) | 0.2402M |
| EPS Diluted (Quarterly) | 19.63 |